Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. (Q51308307)
Jump to navigation
Jump to search
scientific article published on 2 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. |
scientific article published on 2 March 2015 |
Statements
1 reference
Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. (English)
1 reference
R P Kelly
1 reference
P Garhyan
1 reference
E Raddad
1 reference
H Fu
1 reference
C N Lim
1 reference
M J Prince
1 reference
J A Pinaire
1 reference
M T Loh
1 reference
M A Deeg
1 reference
2 March 2015
1 reference
17
1 reference
4
1 reference
414-422
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference